Edition:
United States

AnaptysBio Inc (ANAB.OQ)

ANAB.OQ on NASDAQ Stock Exchange Global Select Market

88.02USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$88.02
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
130,440
52-wk High
$90.50
52-wk Low
$15.19

Select another date:

Tue, Nov 7 2017

BRIEF-Anaptysbio qtrly loss per share $0.45‍​

* Anaptysbio announces third quarter 2017 financial results and provides pipeline updates

BRIEF-AnaptysBio reports positive ANB019 top-line phase 1 clinical trial results

* Anaptysbio reports positive anb019 top-line phase 1 clinical trial results

BRIEF-AnaptysBio prices public offering of 3 mln shares at $68.50 per share

* Says public offering of 3.00 million common shares priced at $68.50per share Source text for Eikon: Further company coverage:

BRIEF-AnaptysBio reports positive data from phase 2A clinical trial of ANB020 in atopic dermatitis

* AnaptysBio reports positive topline proof-of-concept data from phase 2A clinical trial of ANB020 in atopic dermatitis

BRIEF-‍adage Capital reports a 6.05 percent passive stake in AnaptysBio

* ‍Adage Capital Partners GP reports a 6.05 percent passive stake in AnaptysBio Inc​ as of September 22 - SEC filing​ Source text: (http://bit.ly/2yTdILI) Further company coverage:

BRIEF-AnaptysBio reports about 19 pct rise in Q2 revenue

* AnaptysBio announces second quarter 2017 financial results and provides pipeline updates

Select another date: